An Illinois-based developer has received the first approval necessary to build a 140-room extended-stay hotel downtown, as Indy’s lodging market continues to swell.
Eli Lilly and Co., Lilly Corporate Center, Indianapolis, 46285 (www.lilly.com) discovers, develops, manufactures and sells pharmaceutical products for humans and animals.
Indianapolis-based Eli Lilly and Co. and Acrux DDS Pty Ltd. have filed a lawsuit against Lupin Pharmaceuticals Inc. for alleged infringement of patents that cover the testosterone treatment Axiron.
The drug, known as necitumumab, improved patients’ overall chances of survival, yet people taking the medicine also experienced more risk, Food and Drug Administration staff said in a report Tuesday.
Indiana's life sciences companies are spending four times more on medical research than the state's hospitals, doctors and univerities are receiving from such companies for research projects. That means Indiana is missing out on more than $80 million a year.
Michael A. Byers’ Tooth Bank is one of a tiny group of U.S. companies catering to the latest iteration of stem cell therapy: harvesting stem cells from the pulp inside baby teeth and extracted wisdom teeth, then culturing, freezing and storing them at a cryostorage facility for later use.
Gary Hobbs and his wife, Lori, have built BWI LLC into a fast-growing developer of affordable housing with 48 employees and more than $10 million in annual revenue.
Eli Lilly and Co. got good news and bad news about its top-selling drug, the lung cancer therapy Alimta. According to Bloomberg News, a British court upheld a patent protecting a vitamin regimen administered with the drug and said that patent would be infringed by a generic competitor. Lilly's patent protecting Alimta's chemical makeup expires […]
Eli Lilly and Co. is preparing to release data on its experimental Alzheimer’s disease treatment, solanezumab, after years of sometimes positive but often discouraging research.
Indiana’s latest pitch to lure business received national attention and stirred up some controversy. Yet that is exactly what a full-page ad in The Wall Street Journal is meant to do. So, mission accomplished.
London Mayor Boris Johnson is proposing a $16 billion fund to encourage growth of emerging health-care companies in the United Kingdom in an effort to catch up to biotechnology clusters in the United States.
Eli Lilly and Co. received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Eli Lilly and Co. has been ordered to face claims it misled consumers about “brain zaps” and other withdrawal side effects tied to its antidepressant Cymbalta in the first cases slated to be heard by juries.
In a new scoring system for oncology drugs, a leading group of U.S. cancer doctors awarded a zero for overall benefit to a regimen featuring Alimta, Eli Lilly and Co.’s top-selling product.
Eli Lilly and Co.’s shares have risen more than 5 percent this month—and more than 20 percent so far this year—as its pipeline has delivered a string of positive results. This month alone, the Indianapolis-based drugmaker has reported positive results from clinical trials of four experimental drugs. And next month, Lilly will release more data […]
After years of pipeline failures, Eli Lilly and Co. is on a bit of a hot streak. This month alone, the Indianapolis-based drugmaker has reported positive results from clinical trials of four experimental drugs.
Noblesville-based Diamond Charts LLC has become a huge hit among college baseball teams big and small since two Rose-Hulman Institute of Technology alumni launched it in early 2013 with $200 and what seemed like a crazy idea.
